The research, funded by the British Heart Foundation and published in the journal Circulation, opens the prospect of treating the condition at the earliest stages.
Q&A: FDA’s Peter Marks ready to encourage more accelerated approvals for rare diseases
FDA biologics center director Peter Marks said the agency plans to encourage sponsors to use the accelerated approval pathway, particularly for rare disease treatments, as
August 17, 2023